NASDAQ
Orchestra BioMed Holdings, Inc. (OBIO) has a price/sales ratio of 4.76x as of Friday, May 22, 2026. This represents a 173.47% increase compared to its 12-month average of -6.48x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.